A carregar...
HOSPITAL INITIATED INJECTABLE OPIOID AGONIST THERAPY FOR THE TREATMENT OF SEVERE OPIOID USE DISORDER
BACKGROUND: Across North America, there is an unprecedented opioid overdose epidemic. Approximately 15% of individuals with severe opioid use disorder (OUD) do not benefit from opioid agonist therapy (OAT) such as buprenorphine/naloxone or methadone and are considered treatment refractory. Of those...
Na minha lista:
| Publicado no: | J Addict Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7927900/ https://ncbi.nlm.nih.gov/pubmed/32769776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ADM.0000000000000713 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|